Q4 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: OKYO Pharma(OKYO) the Revenue is 0 (--%), Meet estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBIT
TBA--
-0.00B--
----
EPS
TBA--
-0.03--
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf